secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2026-08-21T21:15:33+00:00
Accession:  0001493152-26-039724
Event type: m_and_a
Sentiment:  negative
Materiality: 0.75
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals and Nuclea Energy terminate $15M-PIPE business combination deal
------------------------------------------------------------------------------

- Mutually terminated BCA dated July 29, 2026 on Aug 19, 2026 via Section 12.1(a).
- PIPE minimum of $15M could not be raised before Aug 21, 2026 outside date.
- Each party bears own costs; mutual releases except for willful breach.
- Surviving provisions: Section 9.5, Section 12.2, Article 13 remain in effect.
- No breach admitted by either party; no penalties other than willful breach liability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226039724/0001493152-26-039724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226039724/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer